Macular fold after limited macular translocation treated with scleral shortening release and intravitreal gas.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11704048.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To describe a case developing a macular fold as a complication of limited macular translocation, which was successfully managed without repeat vitrectomy. Interventional case report. A 34-year-old woman who underwent limited macular translocation for subfoveal choroidal neovascularization secondary to myopic degeneration developed a postoperative macular fold. Her visual acuity deteriorated from 20/100 to 20/200 postoperatively. She underwent scleral shortening release and intravitreal gas injection 4 days after the initial surgery and had a resolution of macular fold with adequate foveal displacement. Her visual acuity had improved to 20/40 3 months postoperatively. Scleral shortening release and intravitreal gas injection may be considered for the management of severe macular fold caused by limited macular translocation.
Medical subject headings
- Macula Lutea
- Postoperative Complications
- Retinal Diseases
- Sclera
- Sulfur Hexafluoride